Effects of long-term fenofibrate therapy on cardiovascular events in people with type 2 diabetes mellitus.
Reasner
Charles A
CA
University of Texas Health Science Center in San Antonio, Texas Diabetes Institute, San Antonio, TX 78207, USA. Charles.Reasner@uhs-sa.com
D002318:Cardiovascular Diseases / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D011345:Fenofibrate / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; D011345:Fenofibrate